Search Results

Search Results for "depuy"

• Bonuses cut for executives at troubled J&J
  According to a story on the Huffington Post, Johnson & Johnson has lowered its planned bonuses for the company’s top executives by 10 percent. A statement from the company acknowledges “disappointments” from 2012, and resultant damage to the company’s public reputation. Johnson & Joh...

• Buffett sours on Johnson & Johnson
  Health care giant Johnson & Johnson’s legal troubles are apparently giving investor Warren Buffett pause, according to a blog item for the Philadelphia Inquirer. Buffett recently released his annual letter to shareholders of Berkshire Hathaway, and it shows that Berkshire had dropped its holdi...

• Diabetes drug could be a ‘blockbuster’
  A blog post on Forbes deals with Johnson & Johnson’s type 2 diabetes drug Canagliflozin, which is expected to receive FDA approval soon and which the report describes as having “blockbuster potential.” According to the report, Canagliflozin proved effective at lowering blood glucose levels...

• Hip case exposes unethical doctor conduct
  An opinion piece in the New York Times explores an issue that emerged in the course of a trial over DePuy Orthopaedics’ ASR hip implants – doctors who remain silent over harmful medical devices or drugs. Although experts say doctors have an ethical responsibility to speak out in such cases, they...

• FDA says hip implants more likely to fail in women
  A new study funded by the U.S. Food and Drug Administration reports that artificial hip implants are more likely to prematurely fail and need replacement for female patients, according to a CBS News story. The story says researchers at Weill Cornell Medical College in New York City analyzed the resu...

• Editorial: J&J’s hid info about hip implant problems
  An editorial in the Newark Star Ledger titled “Another black eye for J&J” says that Johnson & Johnson’s actions with regards to its ASR hip replacement were not only unethical, but would have landed an individual in prison. Johnson & Johnson recalled the implants, made by subsidiar...

• Hip replacements safe, but not metal implants
  Although a recent study found that hip implants are more likely to fail in women than in men, the study authors emphasized that hip replacement is still a very safe surgery overall. In analyzing the results for 35,000 hip implant recipients, researchers at Weill Cornell Medical College in New York C...

• Lawyer says company endangered patients
  In closing arguments for a trial involving Johnson & Johnson’s all-metal hip implant, a lawyer representing a 65-year-old former prison guard who claims he contracted metal poisoning from the device said the company put profits ahead of patient safety. The case, which is being heard in Los Ang...

• J&J must pay $181M as part of Medicare fraud case
  Johnson & Johnson has been ordered to pay $181 million to a Houston law firm that worked on behalf of the state of Arkansas in a Medicare fraud case against the company. A Reuters story says that payment is part of a $1.2 billion settlement the company agreed to pay Arkansas in 2012, based on th...

• Government investigating J&J over medical devices
  Johnson & Johnson has disclosed that the government is investigating possible false claims connected to two of the company’s medical devices, Bloomberg reports. The ASR artificial hip implant, manufactured by Johnson & Johnson subsidiary DePuy Orthopaedics, has been the basis of about 10,0...